- ESI value allows to define in each patient, by a standard spirometry, whether airflow obstruction is due to inflammatory narrowing of the conductive airways (chronic bronchitis, bronchiolitis, small airway disease) or to the destruction of lung parenchyma caused by Emphysema.
- Identifying the cause of airway obstruction is crucial in the diagnosis and treatment of Chronic Obstructive Pulmonary Disease (COPD). Patients with the same level of obstruction (FEV1) may reflect very different underlying conditions.
- ESI makes this difference visible, supporting targeted therapeutic strategies.
- Distinctive features
- ESI NEW
- Assess the presence and the severity of Emphysema
through standard spirometry - Plug & Play
- Device powered via integrated USB cable, without screen, without internal memory, and with direct data recording on MIR Spiro Software
- The device is highly resistant to shocks and vibrations, with robust cable protection
All the features
- EMR/EHR Integration
Seamless integration via MIR Spiro Software with EMR/EHR systems using HL7, GDT, FHIR, and Exchange Protocol
- Predicted values
Wide selection of predicted values including GLI, and ERS, among others
- Real-Time Testing
FVC, VC, MVV, PRE/POST bronchodilator comparison
- Interpretation Flexibility NEW
Supports both ATS/ERS 2019 and ATS/ERS 2021 interpretative criteria, allowing physicians to choose their preferred standard
- Pediatric Incentive
Real-time animation to improve patient compliance during the test
- Integrated Temperature Sensor
Automatic BTPS conversion for accurate and standardized measurements
Reviews
There are no reviews yet.